Moderna is anchor client in new Azzur on-demand cleanroom facility
Azzur Cleanrooms on Demand (COD) announced this week that it is expanding its ongoing business relationship with Moderna Inc.
Azzur Cleanrooms on Demand (COD) announced this week that it is expanding its ongoing business relationship with Moderna Inc.
Earlier this month, Rentschler Biopharma, a contract development and manufacturing organization (CDMO), announced that it had broken ground on its new production facility, adjacent to its existing site in Milford, Massachusetts, in the greater Boston area.
Special Edition: Meeting demand for viral vectors
Insufficient manufacturing capacity has led to a shortage of viral vectors. What can be done to boost production?
Special Edition: Meeting demand for viral vectors
Recombinant adeno-associated viruses (rAAVs) are becoming the vector of choice for delivering gene therapies, says the French firm.
Special Edition: Meeting demand for viral vectors
VIVEbiotech, a lentivirus-specialized contract development and manufacturing organization (CDMO) that produces vectors for projects from early-stage to GMP production, is working on enhancing intrinsic lentivirus characteristics and streamlining the...
Mirus Bio expands its product line to meet demand for viral vectors required in cell and gene therapy manufacture at commercial scale.